The impact of T1DM is less clear, because the results of human studies are controversial and the metabolic derangements and the phenotype may be attenuated or masked by insulin treatment, since glycemic control reduces the prevalence of diabetic cardiomyopathy and of CVD [10]. Here, INS is linked to type 1 diabetes mellitus.